Index -
P/E 100.25
EPS (ttm) 0.87
Insider Own 2.04%
Shs Outstand 188.60M
Perf Week 3.84%
Market Cap 16.48B
Forward P/E 32.53
EPS next Y 2.68
Insider Trans -2.93%
Shs Float 184.83M
Perf Month -1.20%
Income 167.65M
PEG 2.33
EPS next Q 0.33
Inst Own 99.28%
Short Float 1.60%
Perf Quarter -10.77%
Sales 2.42B
P/S 6.81
EPS this Y 81.99%
Inst Trans 2.04%
Short Ratio 2.26
Perf Half Y -3.35%
Book/sh 26.25
P/B 3.33
EPS next Y 69.57%
ROA 2.54%
Short Interest 2.96M
Perf Year -4.48%
Cash/sh 5.69
P/C 15.35
EPS next 5Y 43.00%
ROE 3.51%
52W Range 76.02 - 100.38
Perf YTD -9.42%
Dividend Est. -
P/FCF 263.37
EPS past 5Y -
ROI 3.00%
52W High -12.99%
Beta 0.31
Dividend TTM -
Quick Ratio 1.57
Sales past 5Y 10.23%
Gross Margin 76.15%
52W Low 14.89%
ATR (14) 1.73
Dividend Ex-Date -
Current Ratio 2.51
EPS Y/Y TTM 16.20%
Oper. Margin 8.01%
RSI (14) 52.33
Volatility 1.84% 1.91%
Employees 3401
Debt/Eq 0.23
Sales Y/Y TTM 18.16%
Profit Margin 6.93%
Recom 1.76
Target Price 109.52
Option/Short Yes / Yes
LT Debt/Eq 0.13
EPS Q/Q 8269.23%
Payout 0.00%
Rel Volume 0.75
Prev Close 88.61
Sales Surprise 1.16%
EPS Surprise -43.73%
Sales Q/Q 25.23%
Earnings Feb 22 AMC
Avg Volume 1.31M
Price 87.34
SMA20 1.80%
SMA50 -0.99%
SMA200 -2.19%
Trades
Volume 977,724
Change -1.43%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-15-23 Initiated
Wells Fargo
Overweight
$100
Oct-23-23 Upgrade
Bernstein
Underperform → Mkt Perform
$82
Sep-28-23 Initiated
Raymond James
Mkt Perform
Sep-18-23 Initiated
UBS
Buy
$120
Jul-27-23 Initiated
Scotiabank
Sector Perform
$95
Jul-05-23 Upgrade
BMO Capital Markets
Market Perform → Outperform
$102
Jun-14-23 Resumed
Credit Suisse
Outperform
$120
Mar-21-23 Initiated
Bernstein
Underperform
$81
Feb-22-23 Downgrade
Oppenheimer
Outperform → Perform
Feb-21-23 Initiated
Citigroup
Neutral
$116
Jan-30-23 Initiated
BMO Capital Markets
Market Perform
$107
Jan-18-23 Initiated
Canaccord Genuity
Hold
$119
Oct-31-22 Upgrade
Oppenheimer
Perform → Outperform
$92 → $110
Jul-13-22 Initiated
Cantor Fitzgerald
Overweight
$110
Jun-13-22 Resumed
Wedbush
Neutral
$146 → $70
Apr-25-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$96 → $113
Nov-22-21 Upgrade
William Blair
Mkt Perform → Outperform
Oct-07-21 Resumed
Jefferies
Buy
$100
Sep-09-21 Upgrade
Stifel
Hold → Buy
$86 → $96
Jun-04-21 Resumed
Robert W. Baird
Outperform
$101
Show Previous Ratings
Mar-17-24 08:50AM
Mar-16-24 05:06AM
Mar-12-24 08:30AM
Mar-11-24 10:00AM
Mar-08-24 01:31AM
08:30AM
Loading…
Mar-07-24 08:30AM
Mar-01-24 09:00AM
Feb-27-24 12:03AM
Feb-26-24 02:36PM
02:12PM
Feb-23-24 04:29PM
12:33PM
11:34AM
07:21AM
(Thomson Reuters StreetEvents)
05:43AM
04:25AM
Loading…
04:25AM
Feb-22-24 06:00PM
05:15PM
04:42PM
04:23PM
(Associated Press Finance)
04:03PM
Feb-19-24 09:15AM
Feb-15-24 10:00AM
Feb-13-24 01:10PM
Feb-08-24 04:10PM
08:00AM
Feb-07-24 05:21AM
Feb-06-24 08:30AM
Jan-24-24 11:21AM
Jan-23-24 08:00AM
05:06AM
Loading…
Jan-20-24 05:06AM
Jan-15-24 09:45AM
Jan-10-24 06:16PM
Jan-03-24 08:00AM
Dec-21-23 06:14AM
Dec-20-23 05:08PM
04:05PM
Dec-14-23 07:05PM
Dec-05-23 11:01AM
Dec-02-23 05:06AM
Dec-01-23 11:31AM
Nov-29-23 09:13PM
06:30AM
Nov-28-23 11:09AM
08:30AM
Nov-16-23 08:47AM
Nov-10-23 12:58AM
Nov-09-23 04:43PM
03:49AM
Nov-08-23 05:19AM
Nov-07-23 07:09PM
(Morningstar Research) +12.16%
05:07PM
(Investor's Business Daily)
02:24PM
Nov-06-23 07:20PM
Nov-04-23 05:06AM
Nov-03-23 01:23AM
Nov-02-23 05:02PM
12:17PM
08:44AM
07:15AM
Nov-01-23 06:30PM
05:55PM
05:02PM
(Associated Press Finance)
04:05PM
04:02PM
Oct-27-23 07:15AM
Oct-26-23 11:28AM
10:02AM
Oct-25-23 10:02AM
Oct-23-23 09:50AM
Oct-20-23 04:20PM
04:11PM
04:05PM
Oct-19-23 12:17PM
08:15AM
Oct-18-23 12:10PM
Oct-17-23 08:30AM
Sep-23-23 05:06AM
Sep-21-23 10:00AM
Sep-18-23 10:52AM
09:55AM
Sep-15-23 12:50PM
(Investor's Business Daily)
09:29AM
08:37AM
(Investor's Business Daily)
Sep-11-23 08:30AM
Sep-06-23 08:30AM
Sep-05-23 08:30AM
Sep-02-23 05:06AM
Sep-01-23 11:31AM
Aug-31-23 11:31AM
Aug-30-23 04:05PM
Aug-12-23 05:06AM
Aug-01-23 01:37PM
12:35PM
12:06PM
(Thomson Reuters StreetEvents)
Jul-31-23 07:30PM
05:35PM
04:29PM
04:03PM
Jul-27-23 09:56AM
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Slamon Dennis Director Mar 18 '24 Option Exercise 79.70 10,000 797,000 40,809 Mar 20 05:13 PM BIENAIME JEAN JACQUES Director Mar 06 '24 Sale 86.71 1,000 86,713 560,203 Mar 07 05:35 PM FUCHS HENRY J President, Worldwide R&D Mar 05 '24 Sale 85.18 35,341 3,010,396 212,117 Mar 07 06:54 PM Ajer Jeffrey Robert EVP, Chief Commercial Officer Mar 05 '24 Sale 87.07 4,000 348,280 94,047 Mar 07 05:32 PM BIENAIME JEAN JACQUES Director Mar 05 '24 Sale 85.51 1,000 85,510 561,203 Mar 07 05:35 PM BIENAIME JEAN JACQUES Director Feb 27 '24 Sale 90.35 1,000 90,350 562,203 Feb 29 05:05 PM BIENAIME JEAN JACQUES Director Feb 09 '24 Option Exercise 63.10 15,000 946,500 434,602 Feb 12 05:20 PM BIENAIME JEAN JACQUES Director Feb 09 '24 Sale 88.28 15,000 1,324,200 419,602 Feb 12 05:20 PM BIENAIME JEAN JACQUES Director Feb 08 '24 Option Exercise 63.10 15,000 946,500 434,602 Feb 12 05:20 PM BIENAIME JEAN JACQUES Director Feb 08 '24 Sale 89.77 15,000 1,346,550 419,602 Feb 12 05:20 PM BIENAIME JEAN JACQUES Director Jan 10 '24 Option Exercise 63.10 10,000 631,000 435,162 Jan 11 02:40 PM BIENAIME JEAN JACQUES Director Jan 10 '24 Sale 96.38 10,000 963,800 425,162 Jan 11 02:40 PM BIENAIME JEAN JACQUES Director Jan 09 '24 Option Exercise 63.10 10,000 631,000 435,162 Jan 11 02:40 PM BIENAIME JEAN JACQUES Director Jan 09 '24 Sale 98.19 10,000 981,900 425,162 Jan 11 02:40 PM BIENAIME JEAN JACQUES Director Dec 21 '23 Option Exercise 63.10 10,000 631,000 435,112 Dec 22 05:14 PM BIENAIME JEAN JACQUES Director Dec 21 '23 Sale 93.99 10,000 939,900 425,112 Dec 22 05:14 PM Davis George Eric EVP, Chief Legal Officer Dec 13 '23 Sale 95.30 13,764 1,311,709 55,710 Dec 14 06:18 PM Ajer Jeffrey Robert EVP, Chief Commercial Officer Aug 16 '23 Sale 90.00 5,000 450,000 60,804 Aug 17 03:57 PM FUCHS HENRY J President, Worldwide R&D Aug 10 '23 Sale 90.43 12,000 1,085,111 176,187 Aug 11 01:59 PM Guyer Charles Greg EVP, Chief Technical Officer Aug 09 '23 Sale 93.30 5,360 500,109 40,041 Aug 10 04:47 PM Davis George Eric EVP, Chief Legal Officer Aug 08 '23 Sale 89.42 11,000 983,662 69,474 Aug 09 07:08 PM BIENAIME JEAN JACQUES Chief Executive Officer Aug 08 '23 Sale 88.29 6,000 529,740 422,732 Aug 09 07:05 PM BIENAIME JEAN JACQUES Chief Executive Officer Aug 07 '23 Sale 88.10 4,000 352,400 428,732 Aug 09 07:05 PM BIENAIME JEAN JACQUES Chief Executive Officer May 12 '23 Option Exercise 67.81 46,500 3,153,165 472,713 May 16 05:22 PM MEIER RICHARD A Director May 12 '23 Option Exercise 67.81 8,500 576,385 117,494 May 17 06:14 PM HERON ELAINE J Director May 12 '23 Option Exercise 67.81 8,500 576,385 94,068 May 17 06:14 PM BIENAIME JEAN JACQUES Chief Executive Officer May 11 '23 Option Exercise 67.81 30,000 2,034,300 456,213 May 15 04:58 PM BIENAIME JEAN JACQUES Chief Executive Officer May 11 '23 Sale 94.67 30,000 2,840,226 426,213 May 15 04:58 PM BIENAIME JEAN JACQUES Chief Executive Officer May 10 '23 Option Exercise 67.81 30,000 2,034,300 456,213 May 11 05:04 PM BIENAIME JEAN JACQUES Chief Executive Officer May 10 '23 Sale 94.85 30,000 2,845,397 426,213 May 11 05:04 PM BIENAIME JEAN JACQUES Chief Executive Officer May 09 '23 Option Exercise 67.81 30,000 2,034,300 456,213 May 11 05:04 PM BIENAIME JEAN JACQUES Chief Executive Officer May 09 '23 Sale 94.93 30,000 2,847,973 426,213 May 11 05:04 PM BIENAIME JEAN JACQUES Chief Executive Officer Apr 10 '23 Option Exercise 67.81 10,000 678,100 435,896 Apr 12 04:08 PM BIENAIME JEAN JACQUES Chief Executive Officer Apr 10 '23 Sale 99.56 10,000 995,600 425,896 Apr 12 04:08 PM BIENAIME JEAN JACQUES Chief Executive Officer Apr 06 '23 Option Exercise 67.81 10,000 678,100 435,896 Apr 10 07:00 PM BIENAIME JEAN JACQUES Chief Executive Officer Apr 06 '23 Sale 96.13 10,000 961,300 425,896 Apr 10 07:00 PM LAWLIS V BRYAN Director Apr 03 '23 Option Exercise 67.81 8,500 576,385 37,450 Apr 04 07:59 PM LAWLIS V BRYAN Director Apr 03 '23 Sale 97.09 8,500 825,265 28,950 Apr 04 07:59 PM
Index -
P/E 11.58
EPS (ttm) 19.84
Insider Own 7.84%
Shs Outstand 47.04M
Perf Week -3.04%
Market Cap 10.81B
Forward P/E 9.43
EPS next Y 24.37
Insider Trans -7.15%
Shs Float 43.37M
Perf Month 1.07%
Income 984.80M
PEG 1.19
EPS next Q 5.79
Inst Own 94.72%
Short Float 4.42%
Perf Quarter 6.91%
Sales 2.33B
P/S 4.64
EPS this Y 18.78%
Inst Trans 1.05%
Short Ratio 4.72
Perf Half Y -1.18%
Book/sh 127.23
P/B 1.81
EPS next Y 3.56%
ROA 14.81%
Short Interest 1.92M
Perf Year 4.93%
Cash/sh 63.62
P/C 3.61
EPS next 5Y 9.70%
ROE 18.27%
52W Range 204.44 - 261.54
Perf YTD 4.47%
Dividend Est. -
P/FCF 14.46
EPS past 5Y 8.15%
ROI 15.67%
52W High -12.17%
Beta 0.53
Dividend TTM -
Quick Ratio 4.28
Sales past 5Y 8.02%
Gross Margin 88.94%
52W Low 12.37%
ATR (14) 7.56
Dividend Ex-Date -
Current Ratio 4.41
EPS Y/Y TTM 31.54%
Oper. Margin 50.91%
RSI (14) 45.20
Volatility 4.19% 3.18%
Employees 1168
Debt/Eq 0.12
Sales Y/Y TTM 20.20%
Profit Margin 42.31%
Recom 1.56
Target Price 291.75
Option/Short Yes / Yes
LT Debt/Eq 0.05
EPS Q/Q 63.02%
Payout 0.00%
Rel Volume 2.74
Prev Close 243.27
Sales Surprise 6.90%
EPS Surprise 1.76%
Sales Q/Q 25.07%
Earnings Feb 21 BMO
Avg Volume 406.62K
Price 229.72
SMA20 -3.64%
SMA50 1.78%
SMA200 0.54%
Trades
Volume 1,114,533
Change -5.57%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-12-24 Upgrade
Goldman
Sell → Neutral
$213 → $215
Feb-05-24 Initiated
Leerink Partners
Outperform
$330
Dec-08-23 Initiated
Wells Fargo
Overweight
$309
Dec-06-22 Initiated
UBS
Buy
$320
Dec-05-22 Initiated
Goldman
Sell
$230
Oct-11-22 Initiated
Morgan Stanley
Overweight
$288
Sep-20-22 Reiterated
BofA Securities
Underperform
Sep-19-22 Resumed
Wedbush
Outperform
$263
Feb-11-22 Initiated
BTIG Research
Neutral
Jul-14-21 Upgrade
Argus
Hold → Buy
$205
Apr-26-21 Resumed
Credit Suisse
Outperform
$196
Feb-01-21 Upgrade
H.C. Wainwright
Neutral → Buy
$125 → $195
Sep-14-20 Resumed
JP Morgan
Overweight
$142
Jun-25-20 Reiterated
H.C. Wainwright
Neutral
$85 → $125
Mar-10-20 Upgrade
Jefferies
Hold → Buy
$123
Feb-27-20 Upgrade
Cowen
Market Perform → Outperform
$119 → $145
Jan-31-20 Upgrade
JP Morgan
Neutral → Overweight
$120
Dec-03-19 Initiated
BofA/Merrill
Underperform
Aug-01-19 Upgrade
Ladenburg Thalmann
Neutral → Buy
$103 → $106
Aug-01-19 Upgrade
Jefferies
Underperform → Hold
$90
Show Previous Ratings
Mar-27-24 07:00PM
Mar-26-24 10:00AM
07:00AM
Mar-25-24 07:00PM
07:00AM
09:04PM
Loading…
Mar-22-24 09:04PM
11:30AM
Mar-21-24 07:01PM
Mar-17-24 08:50AM
Mar-16-24 02:42PM
Mar-13-24 10:54PM
(Thomson Reuters StreetEvents)
03:12PM
Mar-11-24 07:01PM
Mar-09-24 01:09PM
Mar-08-24 03:01AM
06:28AM
Loading…
Mar-05-24 06:28AM
06:00AM
Feb-27-24 06:00AM
Feb-26-24 07:31PM
03:20PM
Feb-23-24 05:40AM
Feb-22-24 12:22PM
09:55AM
09:54AM
09:45AM
01:16AM
(Thomson Reuters StreetEvents)
12:03AM
Feb-21-24 03:17PM
09:30AM
06:51AM
06:31AM
Loading…
06:31AM
06:24AM
06:15AM
(Associated Press Finance)
06:14AM
06:04AM
06:00AM
05:55AM
Feb-20-24 08:48AM
Feb-19-24 09:15AM
Feb-15-24 11:35PM
Feb-14-24 06:00AM
01:51AM
Feb-07-24 12:10PM
Feb-05-24 10:10AM
Feb-02-24 09:10PM
Jan-25-24 08:32AM
Jan-22-24 05:27PM
Jan-18-24 07:58PM
Jan-16-24 03:57PM
Jan-06-24 07:01AM
Jan-01-24 09:45AM
Dec-29-23 06:00AM
Dec-24-23 05:34PM
Dec-22-23 07:01AM
Dec-19-23 01:01PM
Dec-15-23 09:50AM
05:06AM
Dec-13-23 09:15AM
Dec-12-23 06:00AM
Dec-11-23 09:45AM
Dec-08-23 09:05AM
03:27AM
Dec-07-23 06:00AM
Dec-06-23 09:18PM
Dec-01-23 11:31AM
Nov-24-23 09:50AM
Nov-18-23 07:03AM
Nov-14-23 04:05PM
Nov-13-23 09:50PM
Nov-09-23 11:12AM
03:49AM
Nov-08-23 12:30PM
Nov-06-23 12:19AM
Nov-03-23 11:43PM
Nov-02-23 02:34PM
01:15PM
Nov-01-23 11:00PM
(Thomson Reuters StreetEvents)
09:35AM
09:30AM
09:21AM
07:15AM
06:04AM
(Associated Press Finance)
06:00AM
Oct-31-23 06:05AM
06:00AM
Oct-30-23 06:05AM
Oct-26-23 10:02AM
Oct-25-23 10:02AM
06:00AM
Oct-20-23 09:55PM
Oct-17-23 09:50AM
Oct-02-23 11:34AM
Sep-28-23 10:56AM
Sep-22-23 11:01PM
02:15PM
Sep-20-23 04:15PM
Sep-12-23 06:00AM
Sep-09-23 01:03AM
Sep-01-23 06:00AM
Aug-20-23 10:00AM
(The Wall Street Journal)
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 26 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 27 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 26 '24 Sale 248.33 15,000 3,724,939 130 Mar 27 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 25 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 27 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 25 '24 Sale 243.36 15,000 3,650,401 130 Mar 27 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 22 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 25 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 22 '24 Sale 237.05 15,000 3,555,823 130 Mar 25 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 21 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 25 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Mar 21 '24 Option Exercise 117.76 6,000 706,560 42,710 Mar 22 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 21 '24 Sale 236.34 15,000 3,545,158 130 Mar 25 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Mar 21 '24 Sale 236.45 6,000 1,418,726 36,710 Mar 22 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 20 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 21 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 20 '24 Sale 235.95 15,000 3,539,273 130 Mar 21 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 19 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 21 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 19 '24 Sale 236.59 15,000 3,548,922 130 Mar 21 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 14 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 15 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 14 '24 Sale 237.82 15,000 3,567,243 130 Mar 15 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 13 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 15 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 13 '24 Sale 242.80 15,000 3,641,949 130 Mar 15 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 12 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 13 04:30 PM Olian Judy D. Director Mar 12 '24 Option Exercise 175.43 5,000 877,150 12,305 Mar 13 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 12 '24 Sale 247.95 15,000 3,719,247 130 Mar 13 04:30 PM Olian Judy D. Director Mar 12 '24 Sale 248.20 5,000 1,241,006 7,305 Mar 13 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 11 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 13 04:30 PM Thompson Tommy G Director Mar 11 '24 Option Exercise 88.03 5,000 440,150 13,480 Mar 12 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 11 '24 Sale 248.00 15,000 3,720,056 130 Mar 13 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 08 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 11 04:30 PM Klein Katherine J Director Mar 08 '24 Option Exercise 123.75 9,791 1,211,636 13,431 Mar 11 04:30 PM Thompson Tommy G Director Mar 08 '24 Option Exercise 88.03 2,000 176,060 10,480 Mar 11 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 08 '24 Sale 241.84 15,000 3,627,607 130 Mar 11 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 07 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 11 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Mar 07 '24 Option Exercise 117.76 6,000 706,560 42,599 Mar 07 04:52 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 07 '24 Sale 240.31 15,000 3,604,633 130 Mar 11 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Mar 07 '24 Sale 237.38 6,000 1,424,309 36,599 Mar 07 04:52 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 06 '24 Option Exercise 129.49 15,000 1,942,350 15,130 Mar 07 04:30 PM Giltner Richard Director Mar 06 '24 Option Exercise 88.03 10,000 880,300 25,620 Mar 07 04:30 PM Thompson Tommy G Director Mar 06 '24 Option Exercise 88.03 2,000 176,060 10,480 Mar 07 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 06 '24 Sale 236.25 15,000 3,543,793 130 Mar 07 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 05 '24 Option Exercise 129.49 6,300 815,787 6,430 Mar 07 04:30 PM ROTHBLATT MARTINE A CHAIRPERSON & CEO Mar 05 '24 Sale 230.93 6,300 1,454,886 130 Mar 07 04:30 PM Thompson Tommy G Director Mar 01 '24 Option Exercise 88.03 2,000 176,060 10,480 Mar 04 04:33 PM KURZWEIL RAY Director Feb 23 '24 Option Exercise 88.03 15,000 1,320,450 26,180 Feb 26 04:30 PM Thompson Tommy G Director Feb 23 '24 Option Exercise 88.03 2,000 176,060 10,480 Feb 26 04:30 PM PATUSKY CHRISTOPHER Director Feb 23 '24 Sale 224.00 1,680 376,320 4 Feb 26 04:31 PM MAHON PAUL A EVP & GENERAL COUNSEL Feb 15 '24 Option Exercise 117.76 6,000 706,560 42,599 Feb 15 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Feb 15 '24 Sale 215.31 6,000 1,291,885 36,599 Feb 15 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Feb 01 '24 Option Exercise 117.76 6,000 706,560 42,599 Feb 02 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Feb 01 '24 Sale 215.01 6,000 1,290,083 36,599 Feb 02 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Jan 18 '24 Option Exercise 117.76 6,000 706,560 42,599 Jan 18 05:56 PM MAHON PAUL A EVP & GENERAL COUNSEL Jan 18 '24 Sale 218.72 6,000 1,312,322 36,599 Jan 18 05:56 PM MAHON PAUL A EVP & GENERAL COUNSEL Jan 04 '24 Option Exercise 117.76 6,000 706,560 42,599 Jan 05 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Jan 04 '24 Sale 227.97 6,000 1,367,798 36,599 Jan 05 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Dec 21 '23 Option Exercise 117.76 6,000 706,560 42,599 Dec 26 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Dec 21 '23 Sale 229.27 6,000 1,375,605 36,599 Dec 26 04:30 PM Mesa Nilda Director Dec 19 '23 Sale 244.90 605 148,164 5,698 Dec 20 04:30 PM CAUSEY CHRISTOPHER Director Dec 15 '23 Sale 255.00 400 102,000 4,185 Dec 18 04:30 PM CAUSEY CHRISTOPHER Director Dec 12 '23 Option Exercise 175.43 3,000 526,290 7,585 Dec 13 05:29 PM CAUSEY CHRISTOPHER Director Dec 12 '23 Sale 249.68 3,000 749,034 4,585 Dec 13 05:29 PM MAHON PAUL A EVP & GENERAL COUNSEL Dec 07 '23 Option Exercise 117.76 6,000 706,560 42,599 Dec 07 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Dec 07 '23 Sale 238.89 6,000 1,433,331 36,599 Dec 07 04:30 PM Giltner Richard Director Dec 01 '23 Option Exercise 88.03 5,000 440,150 20,620 Dec 04 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Nov 16 '23 Option Exercise 117.76 6,000 706,560 42,599 Nov 17 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Nov 16 '23 Sale 226.60 6,000 1,359,593 36,599 Nov 17 04:30 PM PATUSKY CHRISTOPHER Director Nov 07 '23 Option Exercise 88.03 2,000 176,060 3,684 Nov 08 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Nov 02 '23 Option Exercise 117.76 6,000 706,560 42,599 Nov 03 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Nov 02 '23 Sale 225.76 6,000 1,354,554 36,599 Nov 03 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Oct 19 '23 Option Exercise 117.76 6,000 706,560 42,599 Oct 20 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Oct 19 '23 Sale 225.43 6,000 1,352,591 36,599 Oct 20 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Oct 05 '23 Option Exercise 117.76 6,000 706,560 42,599 Oct 10 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Oct 05 '23 Sale 223.82 6,000 1,342,923 36,599 Oct 10 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Sep 21 '23 Option Exercise 117.76 6,000 706,560 42,599 Sep 22 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Sep 21 '23 Sale 222.19 6,000 1,333,150 36,599 Sep 22 04:30 PM Mesa Nilda Director Sep 13 '23 Sale 222.36 383 85,164 6,303 Sep 15 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Sep 07 '23 Option Exercise 117.76 6,000 706,560 42,599 Sep 08 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Sep 07 '23 Sale 222.98 6,000 1,337,905 36,599 Sep 08 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Aug 17 '23 Option Exercise 117.76 6,000 706,560 42,599 Aug 18 04:30 PM PATUSKY CHRISTOPHER Director Aug 17 '23 Option Exercise 88.03 2,000 176,060 3,684 Aug 18 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Aug 17 '23 Sale 229.54 6,000 1,377,265 36,599 Aug 18 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Aug 03 '23 Option Exercise 117.76 6,000 706,560 42,599 Aug 04 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Aug 03 '23 Sale 236.25 6,000 1,417,470 36,599 Aug 04 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Jul 20 '23 Option Exercise 120.26 2,500 300,650 39,099 Jul 24 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Jul 20 '23 Sale 243.87 2,500 609,675 36,599 Jul 24 04:30 PM SULLIVAN LOUIS W Director Jul 07 '23 Option Exercise 0.00 880 0 13,060 Jul 07 04:30 PM Thompson Tommy G Director Jul 07 '23 Option Exercise 0.00 880 0 8,480 Jul 07 04:30 PM Olian Judy D. Director Jul 07 '23 Option Exercise 0.00 1,750 0 8,255 Jul 07 04:30 PM Mesa Nilda Director Jul 07 '23 Option Exercise 0.00 880 0 6,686 Jul 07 04:30 PM KURZWEIL RAY Director Jul 07 '23 Option Exercise 0.00 880 0 11,180 Jul 07 04:30 PM Klein Katherine J Director Jul 07 '23 Option Exercise 0.00 880 0 3,640 Jul 07 04:30 PM DWEK RAYMOND Director Jul 07 '23 Option Exercise 0.00 1,750 0 1,750 Jul 07 04:30 PM Giltner Richard Director Jul 07 '23 Option Exercise 0.00 1,750 0 15,620 Jul 07 04:30 PM CAUSEY CHRISTOPHER Director Jul 07 '23 Option Exercise 0.00 1,750 0 4,585 Jul 07 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Jul 06 '23 Option Exercise 120.26 6,000 721,560 42,599 Jul 07 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Jul 06 '23 Sale 215.19 6,000 1,291,165 36,599 Jul 07 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Jun 15 '23 Option Exercise 120.26 6,000 721,560 42,599 Jun 15 05:23 PM MAHON PAUL A EVP & GENERAL COUNSEL Jun 15 '23 Sale 227.77 6,000 1,366,634 36,599 Jun 15 05:23 PM Thompson Tommy G Director Jun 13 '23 Option Exercise 88.03 1,000 88,030 8,600 Jun 14 04:30 PM Thompson Tommy G Director Jun 02 '23 Option Exercise 88.03 1,000 88,030 8,600 Jun 05 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Jun 01 '23 Option Exercise 120.26 6,000 721,560 42,599 Jun 01 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL Jun 01 '23 Sale 209.11 6,000 1,254,677 36,599 Jun 01 04:30 PM Giltner Richard Director May 22 '23 Option Exercise 63.90 5,000 319,500 18,870 May 23 04:30 PM MAHON PAUL A EVP & GENERAL COUNSEL May 18 '23 Option Exercise 120.26 6,000 721,560 42,599 May 18 04:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite